Striving for Health Equity

Increasing Diversity and Inclusion in Life Sciences Clinical Trials

Diversity and Inclusion (D&I) in clinical trials remains a key challenge faced by the healthcare industry today. While many life sciences companies are just beginning down the path of enrolling a more diverse population in their clinical trials, several organizations have already made substantial inroads into ensuring participation in clinical trials better reflects the intended therapy area’s real-world population.

Experts discuss key considerations for assessing and restructuring clinical trial designs and processes to achieve better representation of target populations, including:


  1. Approaches to increasing D&I in clinical research and ways to evaluate how successful they are.
  2. Engaging with external partners to identify and recruit a diverse target patient population.
  3. Trends in regulatory D&I requirements.

Let Us Help Guide You

Complexity demands a trusted guide with the unique expertise and cross-sector versatility to deliver unwavering success. We work with organizations across regulated commercial and public sectors to catalyze transformation and pioneer new directions for the future.

Stay ahead of the curve with news, insights and updates from Guidehouse about issues relevant to your organization and its work.